Cancer Survivorship in Hematologic Malignancies

Status Not yet recruiting

Clinical Trial Summary

General objective: to improve care for haematological cancer survivors. This study will (i) Estimate the incidence of cancer survivor syndrome (CSS) in adult Egyptian patients with haematological neoplasms (HN). (ii) Asses the risk factors of CSS in patients with HN. (iii) Study the effect of CSS on quality of life in patients with HN. (iv) To explore coping strategies of patients with HN having CSS

Clinical Trial Description

According to the American Cancer Society the term cancer survivor refersto people who have no signs of cancer after finishing treatment, people receiving extended treatment over a longer period of time to control the cancer or reduce risk of its return, and people with advanced cancer. Most hematologic malignancies (HM) are incurable and typically follow unpredictable remitting-relapsing pathways associated with varying need for treatment, which may be distressing for patients. Distress symptoms and psychological disorders secondary to cancer have also been shown to have significant negative consequences for both the patient and the family. Maladaptive coping and abnormal illness behavior have been associated with psychiatric conditions, with negative effects on adherence to treatment, health behavior, and quality of life (Grassi et al 2017). Moreover, an increased length of stay in the hospital and/or an increased time in rehabilitation have been found to be more common among patients showing psychiatric symptoms, especially depression, than those with normal adjustment to illness (Cordova et al 2017). Unfortunately, cancer-related distress is commonly underrecognized and subsequently undertreated especially for patients with HM in developing countries. Search in literature revealed several screening methods for the psychological consequences of cancer such as Distress Thermometer , Symptom related checklist questionnaire, Quality of life questionnaire, Coping strategies questionnaire. Also, guidelines for the management of psychological distress have been developed by several scientific cancer associations. ;

Study Design

Related Conditions & MeSH terms

Cancer Survivors

Clinical Trial Details

NCT number	NCT05780411
Study type	Observational
Source	Assiut University
Contact	Roaa M Saleh, MD
Phone	00201010617778
Email	roaasalh043@gmail.com
Status	Not yet recruiting
Phase
Start date	April 1, 2023
Completion date	March 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06028048` - Enhancing Work Participation of Unemployed and Work-Disabled Cancer Survivors	Phase 2/Phase 3
Recruiting	`NCT04439461` - Adaptation and First Step Validation of the ICF Core Set for Vocational Rehabilitation for Cancer Survivors
Completed	`NCT04498130` - Feasibility of a Novel, Theory Based Physical Activity Intervention Among Adult Cancer Survivors	N/A
Completed	`NCT05473026` - Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors	N/A
Active, not recruiting	`NCT05582889` - Move For Your Health for Older Cancer Survivors	N/A
Active, not recruiting	`NCT04339959` - Remote Assessment of Physical Function
Recruiting	`NCT05193149` - Inspiratory Muscle Training in Obese Breast Cancer Survivors	N/A
Recruiting	`NCT03750981` - C.A.P.A.B.L.E. (Cross-Training and Physical Activity: A Better Life Experience Study)	N/A
Completed	`NCT04751305` - Remote Exercise Maintenance With Health Coaching for Cancer Survivors	N/A
Completed	`NCT02152020` - Patient-Centered Acupuncture for Pain (PCAP)	N/A
Recruiting	`NCT05865678` - Musculoskeletal Health in Adult Haematological Cancer Survivors
Recruiting	`NCT06046573` - Pilot Study of Internet-Delivered Psychological Treatment for Cancer Survivors	N/A
Recruiting	`NCT05194397` - Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors	Phase 2
Completed	`NCT01108484` - Program of Exercise, Diet and Control of Psychological Stress in Cancer Survivors	N/A
Recruiting	`NCT06205251` - Diaphragm Structure and Function in Childhood Cancer Survivors	N/A
Completed	`NCT03459781` - Compassion Meditation for Cancer Survivor-Caregiver Dyads	Phase 1/Phase 2
Recruiting	`NCT05519982` - Sleep Treatment Education Program-1 (STEP-1)	N/A
Completed	`NCT03981809` - Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan
Active, not recruiting	`NCT04245943` - Rehabilitation - Physical Activity and Coping	N/A
Active, not recruiting	`NCT04855552` - Telehealth Weight Loss Program for Breast Cancer Survivors	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.